State Street SPDR S&P Biotech ETF (XBI) 最新ニュース、市場動向および感情 | Edgen
戻る
ホーム
株式
XBI
State Street SPDR S&P Biotech ETF (XBI)
XBI 株価推移チャート
XBI
State Street SPDR S&P Biotech ETF
$165.68
-1.51%
$-2.54
終値: Aug 28, 16:00:00 GMT-4
$165.68
0%
$0
アフターマーケット:Aug 28, 19:01:08 GMT-4
概要
予測
保有株式
ニュース
記事
主要データ
前終値
$168.23
始値
$166.78
当日レンジ
$165.29 - $167.12
52週レンジ
$88.23 - $169.68
取引高
1.1M
平均取引高
8.7M
配当利回り
0.37%
純資産
$0
NAV
--
費用率
--
発行済株式数
68.5M
XBIとは何ですか?
XBI was created on 2006-01-31 by SPDR. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 10424.49m in AUM and 148 holdings. XBI tracks an equal-weighted index of US biotechnology stocks.
特徴
株式・暗号通貨用AIコピローター
価格予測
資金調達トラッカー
暗号通貨比較
ホームページ
Markets
US Stocks
HK Stocks
Crypto
News
Analyst Moves
Market Moves
Hong Kong IPO
Earnings
AI & Technology
Macro & Policy
利用規約
プライバシーポリシー
サイトマップ
© 2026 Edgen によって提供
Argus upgrades Moderna to buy with $180 target on vaccine data
Aug 28 2026, 21:27
Oruka Therapeutics jumps 65% on psoriasis drug trial momentum
Aug 28 2026, 16:31
Moderna prices $2.6 billion convertible notes to fund oncology push
Aug 28 2026, 12:25
Biotech's 85% rally faces China's fast-follower drug threat
Aug 28 2026, 12:09
FDA approves Rasonque, nearly doubling pancreatic cancer survival to 13 months
Aug 26 2026, 16:02
Moderna surges 177% as cancer vaccine hype outruns the math
Aug 26 2026, 05:51
Moderna's $69.6B war chest opens door to 4 biotech targets
Aug 20 2026, 13:59
Moderna stock surges 177% as cancer vaccine clears Phase 3 trial
Aug 20 2026, 11:42
Moderna mRNA cancer vaccine clears Phase 3, CanSino jumps 50%
Aug 20 2026, 11:24
S&P 500 gains 0.2% as Treasury buyback expansion eases yields
Aug 20 2026, 00:23
Moderna, Merck melanoma vaccine hits Phase 3 goals, shares surge 40%
Aug 19 2026, 11:43
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00
Aug 10 2026, 00:00